Indee Labs
Winter 2017 · Active
Enabling T cell immunotherapy discovery, development and manufacturing
Location: Berkeley, CA, US
Founded: 2015
Team size: 5
Industries:
About
Intracellular delivery is the most problematic step in T cell immunotherapy discovery, development and manufacturing. Indee Labs is developing a non-viral intracellular delivery system based on microfluidic vortex shedding (µVS) to rapidly deliver nucleic acids, proteins and gene editing complexes to patient and donor T cells with minimal perturbation.
Founders
Ryan PawellFounder/CEO
My career aim is to use technology to improve health outcomes. See more on my LinkedIn profile.